Redox Biology in COPD

慢性阻塞性肺病中的氧化还原生物学

基本信息

项目摘要

DESCRIPTION (provided by applicant): PROJECT SUMMARY/ABSTRACT It is well known that oxidative stress contributes to the pathogenesis of Chronic Obstructive Pulmonary Disease (COPD). However, the exact mechanism whereby changes in the oxidative environment contribute to disease has remained a "black box", and methods to detect specific oxidative modifications in target proteins have been limited. The adverse molecular actions of oxidants have largely been attributed to their role in causing damage. Yet, the concept that oxidants are molecules with regulatory functions important in normal cell and tissue homeostasis has also emerged. The latter signaling function of oxidants has been attributed to cysteine oxidations, such as S-nitrosylation (PSNO), and S-glutathionylation (PSSG). Recent work from our laboratory has determined that PSNO and PSSG are important biochemical events that limit the activation of the pro-inflammatory and pro-survival transcription factor, nuclear factor kappa B (NF-kB) in lung epithelial cells. Importantly, activation of NF-kB has been observed in patients with COPD and is believed to contribute the inflammatory process observed in these patients. To this date, information about changes in the homeostasis of PSNO and PSSG in lungs of patients with COPD, and the interplay between these events, remains largely absent, due to the difficulties to detect these oxidative modifications in situ in tissues. Our laboratory has recently developed two new assays that, for the first time, enable the detection of PSNO and PSSG in paraffin-embedded sections in situ. These recent observations and novel approaches lead us to hypothesize that the homeostasis of PSNO and PSSG is affected in lung tissues from patients with COPD, and that these changes correlate with regional patterns of NF-kB activation. In Specific Aim #1, we will determine the extent of PSNO and PSSG in lung biopsies of patients with COPD. We will utilize the recently developed chemical and catalytic cysteine derivatization strategies to monitor patterns in PSNO and PSSG in paraffin-embedded biopsy specimens from patients with varying severities of COPD using confocal laser scanning microscopy. We will also evaluate normal tissue derived from patients undergoing surgery for lung cancer resection. We will also further validate our assays and implement internal standards in order to improve their diagnostic utility. We will measure expression of glutaredoxin-1 (Grx1) and S-nitrosoglutathione (GSNO) reductase, as these enzymes represent the major regulators of PSSG and PSNO content, respectively. In Specific Aim #2 we will determine whether changes in PSNO and PSSG of NF-kB pathway members can be detected in patients with COPD. Completion of these Specific Aims represents an important validation of the utility of the new assays to detect PSNO and PSSG in tissues in situ. Finalization of this project will yield new insights into the extent to which various cysteine oxidations occur in patients with COPD, and provide insights into their relationship with the status of activation of NF-kB. (End of Abstract) PUBLIC HEALTH RELEVANCE: PROJECT NARRATIVE it is well known that oxidants contribute to damage of lungs of patients with Chronic Obstructive Pulmonary Disease (COPD). However, the exact cellular effects of oxidants have remained unclear which is problematic, because is does not enable investigators to determine whether antioxidant therapies were adequately effective. This laboratory has developed new assays which allow investigators for the first time to study the subtle action of oxidants in tissue slides prepared from lungs. This grant proposal therefore has as its major goal to test the utility of these two new assays to detect oxidative changes in normal lung as well as in lung tissue prepared from patients with increasing severities of COPD. If successful, these new assays may have diagnostic use in testing the extent of oxidative stress in patients with lung disease, and also in determining the effectiveness of antioxidant therapies. Completion of this grant proposal may also offer new insights into the mechanisms whereby oxidants regulate the severity of inflammation.
描述(由申请人提供): 项目摘要/摘要 众所周知,氧化应激导致慢性阻塞性肺疾病 (COPD) 的发病机制。然而,氧化环境的变化导致疾病的确切机制仍然是一个“黑匣子”,检测靶蛋白特定氧化修饰的方法也很有限。氧化剂的不利分子作用很大程度上归因于它们造成损害的作用。然而,氧化剂是具有对正常细胞和组织稳态重要的调节功能的分子的概念也已经出现。氧化剂的后者信号传导功能归因于半胱氨酸氧化,例如S-亚硝基化(PSNO)和S-谷胱甘肽化(PSSG)。我们实验室最近的工作已确定 PSNO 和 PSSG 是重要的生化事件,可限制肺上皮细胞中促炎和促生存转录因子核因子 kappa B (NF-kB) 的激活。重要的是,在 COPD 患者中观察到 NF-kB 的激活,并被认为有助于在这些患者中观察到的炎症过程。迄今为止,由于难以在组织中原位检测这些氧化修饰,因此关于 COPD 患者肺部 PSNO 和 PSSG 稳态变化以及这些事件之间相互作用的信息仍然基本上不存在。我们的实验室最近开发了两种新的检测方法,首次能够在石蜡包埋切片中原位检测 PSNO 和 PSSG。这些最近的观察和新方法使我们推测 COPD 患者肺组织中 PSNO 和 PSSG 的稳态受到影响,并且这些变化与 NF-kB 激活的区域模式相关。在具体目标#1 中,我们将确定 COPD 患者肺活检中 PSNO 和 PSSG 的程度。我们将利用最近开发的化学和催化半胱氨酸衍生化策略,使用共焦激光扫描显微镜监测不同严重程度的 COPD 患者石蜡包埋活检标本中的 PSNO 和 PSSG 模式。我们还将评估来自接受肺癌切除手术的患者的正常组织。我们还将进一步验证我们的检测方法并实施内部标准,以提高其诊断效用。我们将测量谷氧还蛋白-1 (Grx1) 和 S-亚硝基谷胱甘肽 (GSNO) 还原酶的表达,因为这些酶分别代表 PSSG 和 PSNO 含量的主要调节因子。在具体目标#2 中,我们将确定是否可以在 COPD 患者中检测到 NF-kB 通路成员的 PSNO 和 PSSG 变化。这些具体目标的完成代表了对原位组织中 PSNO 和 PSSG 新检测方法实用性的重要验证。该项目的完成将为 COPD 患者中各种半胱氨酸氧化发生的程度提供新的见解,并提供它们与 NF-kB 激活状态的关系的见解。 (摘要完) 公共卫生相关性: 项目叙述 众所周知,氧化剂会导致慢性阻塞性肺病 (COPD) 患者的肺部损伤。然而,氧化剂的确切细胞作用仍不清楚,这是有问题的,因为研究人员无法确定抗氧化疗法是否足够有效。该实验室开发了新的检测方法,使研究人员能够首次研究肺部组织切片中氧化剂的微妙作用。因此,这项拨款提案的主要目标是测试这两种新测定方法的实用性,以检测正常肺以及从慢性阻塞性肺病严重程度增加的患者制备的肺组织中的氧化变化。如果成功,这些新的检测方法可能具有诊断用途,可用于测试肺病患者的氧化应激程度,以及确定抗氧化疗法的有效性。这项拨款提案的完成也可能为氧化剂调节炎症严重程度的机制提供新的见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yvonne M. W. Janssen-Heininger其他文献

Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment
小分子介导的氧化还原酶 ERO1A 的抑制通过损害肿瘤微环境中的血管内皮生长因子和程序性死亡配体 1 来抑制侵袭性乳腺癌
  • DOI:
    10.1038/s41419-025-07426-1
  • 发表时间:
    2025-02-17
  • 期刊:
  • 影响因子:
    9.600
  • 作者:
    Ersilia Varone;Michele Retini;Alessandro Cherubini;Alexander Chernorudskiy;Alice Marrazza;Andrea Guidarelli;Alfredo Cagnotto;Marten Beeg;Marco Gobbi;Stefano Fumagalli;Marco Bolis;Luca Guarrera;Maria Chiara Barbera;Chiara Grasselli;Augusto Bleve;Daniele Generali;Manuela Milani;Michele Mari;Mario Salmona;Giovanni Piersanti;Giovanni Bottegoni;Massimo Broggini;Yvonne M. W. Janssen-Heininger;Jaehyung Cho;Orazio Cantoni;Ester Zito
  • 通讯作者:
    Ester Zito

Yvonne M. W. Janssen-Heininger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yvonne M. W. Janssen-Heininger', 18)}}的其他基金

Glutaredoxin, Glutathione Metabolism and Lung Cancer
谷氧还蛋白、谷胱甘肽代谢与肺癌
  • 批准号:
    10657945
  • 财政年份:
    2023
  • 资助金额:
    $ 7.53万
  • 项目类别:
Collagen Oxidation, Myofibroblast Activation and Age-Associated Pulmonary Fibrosis
胶原蛋白氧化、肌成纤维细胞激活和年龄相关性肺纤维化
  • 批准号:
    10532853
  • 财政年份:
    2022
  • 资助金额:
    $ 7.53万
  • 项目类别:
Collagen Oxidation, Myofibroblast Activation and Age-Associated Pulmonary Fibrosis
胶原蛋白氧化、肌成纤维细胞激活和年龄相关性肺纤维化
  • 批准号:
    10445737
  • 财政年份:
    2021
  • 资助金额:
    $ 7.53万
  • 项目类别:
2020 Oxygen Radicals Gordon Research Conference (GRC) and Gordon Research Seminar (GRS)
2020年氧自由基戈登研究会议(GRC)和戈登研究研讨会(GRS)
  • 批准号:
    9912443
  • 财政年份:
    2020
  • 资助金额:
    $ 7.53万
  • 项目类别:
S-glutathionylation chemistry in fibrotic lung remodeling
纤维化肺重塑中的 S-谷胱甘肽化学
  • 批准号:
    10585922
  • 财政年份:
    2017
  • 资助金额:
    $ 7.53万
  • 项目类别:
S-glutathionylation chemistry in fibrotic lung remodeling
纤维化肺重塑中的 S-谷胱甘肽化学
  • 批准号:
    10320789
  • 财政年份:
    2017
  • 资助金额:
    $ 7.53万
  • 项目类别:
Redox-based Fas signaling in allergic airway disease
过敏性气道疾病中基于氧化还原的 Fas 信号传导
  • 批准号:
    7822474
  • 财政年份:
    2009
  • 资助金额:
    $ 7.53万
  • 项目类别:
Epithelial JNK-TGFb1 Signaling Axis in Airway Remodeling
气道重塑中的上皮 JNK-TGFb1 信号轴
  • 批准号:
    7367482
  • 财政年份:
    2008
  • 资助金额:
    $ 7.53万
  • 项目类别:
Epithelial JNK-TGFb1 Signaling Axis in Airway Remodeling
气道重塑中的上皮 JNK-TGFb1 信号轴
  • 批准号:
    7644952
  • 财政年份:
    2008
  • 资助金额:
    $ 7.53万
  • 项目类别:
Epithelial JNK-TGFb1 Signaling Axis in Airway Remodeling
气道重塑中的上皮 JNK-TGFb1 信号轴
  • 批准号:
    8459777
  • 财政年份:
    2008
  • 资助金额:
    $ 7.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了